NEWS
A terminally ill cancer patient in the United States, who was formerly employed as a school groundskeeper, is testifying in court that working with Monsanto’s Roundup weed killer caused him to develop non-Hodgkin’s lymphoma.
COMMENT
While Monsanto has recently been bought by the pharmaceutical and chemical giant Bayer, its already considerable legal problems are continuing to mount. As recently as a year ago there were more than 800 patients known to be suing Monsanto and ready to testify that Roundup had caused them to develop cancer. Today, however, Timothy Litzenburg, the attorney for the terminally ill groundskeeper who is testifying against Monsanto, says he now represents more than 2,000 non-Hodgkin’s lymphoma sufferers who, prior to their diagnosis, had been using the weed killer “extensively”.
Glyphosate, the key ingredient in Roundup, has already been cited by the World Health Organization’s International Agency for Research on Cancer (IARC) as being “probably carcinogenic to humans.” In a monograph published in March 2015, IARC specifically noted that its classification of the chemical had followed a “comprehensive review of the latest available scientific evidence”. Later, in a study published in 2017, scientists at the Dr. Rath Research Institute further confirmed the damaging effects of glyphosate on cells and described how specific micronutrients applied in proper combinations and dosages can provide some protective effects against it. Not only was this research essentially ignored, evidence has emerged that Monsanto had seemingly manipulated studies on Roundup to conceal its risks.
While Bayer itself was already no stranger to controversy, by purchasing Monsanto it has simultaneously bought itself a whole host of additional problems. The Monsanto name may soon be no more, but its toxic after-effects will doubtless live on for many years to come.
Read article at cnn.com
Study Finds 29 Types Of Pharma Drugs In British Rivers
June 22, 2018Research Sheds Light On Benefits Of Carotenoids For Hearing
June 22, 2018Dying Man Goes To Court To Argue Monsanto Weed Killer Gave Him Cancer
NEWS
A terminally ill cancer patient in the United States, who was formerly employed as a school groundskeeper, is testifying in court that working with Monsanto’s Roundup weed killer caused him to develop non-Hodgkin’s lymphoma.
COMMENT
While Monsanto has recently been bought by the pharmaceutical and chemical giant Bayer, its already considerable legal problems are continuing to mount. As recently as a year ago there were more than 800 patients known to be suing Monsanto and ready to testify that Roundup had caused them to develop cancer. Today, however, Timothy Litzenburg, the attorney for the terminally ill groundskeeper who is testifying against Monsanto, says he now represents more than 2,000 non-Hodgkin’s lymphoma sufferers who, prior to their diagnosis, had been using the weed killer “extensively”.
Glyphosate, the key ingredient in Roundup, has already been cited by the World Health Organization’s International Agency for Research on Cancer (IARC) as being “probably carcinogenic to humans.” In a monograph published in March 2015, IARC specifically noted that its classification of the chemical had followed a “comprehensive review of the latest available scientific evidence”. Later, in a study published in 2017, scientists at the Dr. Rath Research Institute further confirmed the damaging effects of glyphosate on cells and described how specific micronutrients applied in proper combinations and dosages can provide some protective effects against it. Not only was this research essentially ignored, evidence has emerged that Monsanto had seemingly manipulated studies on Roundup to conceal its risks.
While Bayer itself was already no stranger to controversy, by purchasing Monsanto it has simultaneously bought itself a whole host of additional problems. The Monsanto name may soon be no more, but its toxic after-effects will doubtless live on for many years to come.
Read article at cnn.comDr. Rath Health Foundation
Related posts
Persistent Vitamin D Deficiency Common in Breastfed Infants, Hong Kong Study Reveals
Read more